"The US Food and Drug Administration (FDA) has approved the tumor necrosis factor inhibitor adalimumab (Humira, AbbVie) for the treatment of moderate to severe hidradenitis suppurativa (HS), making it the first and only FDA-approved therapy"...
Clinical Studies Experience
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
Skin, scalp, and ocular irritation were monitored in the clinical trials. All subjects were queried about the presence of skin and scalp symptoms; the results are presented in Table 2.
Table 2: Monitored Adverse Reactions - Application Site Symptoms
|Application site Irritation||2% (11/478)||1% (2/336)|
|Application site anesthesia & hypoesthesia||2% (10/478)||0% (0/336)|
|Pain||1% (5/478)||0% (1/336)|
The subset of subjects who did not have pruritus, erythema, edema or pyoderma of skin and scalp, or ocular irritation prior to treatment were assessed for these signs and symptoms after treatment; the results are presented in Table 3.
Table 3: Monitored Adverse Reactions -Pruritus, Erythema,
Pyoderma and Ocular Irritation with Onset After Treatment
|Pruritus||12% (14/116)||4% (3/67)|
|Erythema||10% (32/309)||9% (19/217)|
|Pyoderma||7% (22/308)||4% (10/230)|
|Ocular irritation||6% (26/428)||1% (3/313)|
Other less common reactions (less than 1% but more than 0.1%) were, in decreasing order of incidence: application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, erythema, rash, and skin exfoliation.
Read the Ulesfia (benzyl alcohol lotion for topical use) Side Effects Center for a complete guide to possible side effects
Drug interaction studies were not conducted with Ulesfia (benzyl alcohol lotion for topical use) Lotion.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 7/20/2010
Additional Ulesfia Information
Ulesfia - User Reviews
Ulesfia User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.